See more : Ambrian Plc (AMNZF) Income Statement Analysis – Financial Results
Complete financial analysis of Trees Corporation (CANN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trees Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Asian Star Co. (8946.T) Income Statement Analysis – Financial Results
- Sprout Tiny Homes, Inc. (STHI) Income Statement Analysis – Financial Results
- Jiangxi Huawu Brake Co.,Ltd. (300095.SZ) Income Statement Analysis – Financial Results
- Akumin Inc. (AKU) Income Statement Analysis – Financial Results
- Eyes on the Go, Inc. (AXCG) Income Statement Analysis – Financial Results
Trees Corporation (CANN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.treescann.com
About Trees Corporation
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.14M | 13.44M | 5.93M | 7.12M | 3.67M | 4.62M | 3.52M | 2.98M | 1.76M | 240.21K | 0.00 | 21.03K | 61.56K | 100.64K | 38.00K |
Cost of Revenue | 11.56M | 8.58M | 4.44M | 5.47M | 2.47M | 3.74M | 2.79M | 1.99M | 1.42M | 68.54K | 186.15K | 48.11K | 31.25K | 28.19K | 7.44K |
Gross Profit | 6.57M | 4.87M | 1.49M | 1.65M | 1.20M | 879.76K | 736.37K | 988.48K | 339.95K | 171.67K | -186.15K | -27.08K | 30.31K | 72.45K | 30.57K |
Gross Profit Ratio | 36.24% | 36.20% | 25.10% | 23.21% | 32.71% | 19.05% | 20.91% | 33.15% | 19.28% | 71.47% | 0.00% | -128.75% | 49.24% | 71.99% | 80.43% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.38M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Selling & Marketing | 8.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.67M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Other Expenses | 874.41K | 331.38K | 500.57K | 215.46K | 115.70K | 149.50K | 125.91K | 394.22K | 282.83K | 66.26K | 0.00 | -59.25K | 38.96K | 0.00 | 0.00 |
Operating Expenses | 10.55M | 8.04M | 4.50M | 7.72M | 10.06M | 12.29M | 7.56M | 6.70M | 7.58M | 2.71M | 1.03M | -18.53K | 90.43K | 18.34K | 63.31K |
Cost & Expenses | 22.11M | 16.62M | 8.94M | 13.19M | 12.53M | 16.03M | 10.35M | 8.69M | 9.01M | 2.78M | 1.22M | 29.58K | 121.67K | 46.54K | 70.75K |
Interest Income | 0.00 | 234.38K | 1.31M | 748.78K | 2.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Interest Expense | 2.58M | 2.80M | 1.31M | 748.78K | 2.37M | 4.56M | 1.37M | 6.29M | 1.75M | 1.00M | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Depreciation & Amortization | 2.68M | 1.60M | 991.20K | 485.91K | 115.70K | 62.44K | 125.91K | 394.22K | 282.83K | 66.26K | 962.15K | 23.58K | -1.32K | 107.07K | -250.00 |
EBITDA | -1.64M | -5.37M | -6.12M | -6.19M | -11.33M | -11.51M | -6.73M | -8.83M | -6.96M | -5.86M | 0.00 | -8.55K | -61.43K | 570.00 | -32.74K |
EBITDA Ratio | -9.03% | -21.21% | -39.98% | -80.76% | -236.35% | -247.68% | -190.22% | -178.35% | -394.82% | -1,028.07% | 0.00% | 15.40% | -99.78% | 106.96% | -86.82% |
Operating Income | -3.97M | -3.17M | -3.01M | -6.07M | -8.86M | -11.41M | -7.05M | -7.06M | -7.24M | -2.54M | -962.15K | -20.34K | -60.11K | 570.00 | -32.74K |
Operating Income Ratio | -21.91% | -23.61% | -50.83% | -85.19% | -241.70% | -246.97% | -200.09% | -236.65% | -410.86% | -1,055.65% | 0.00% | -96.72% | -97.64% | 0.57% | -86.16% |
Total Other Income/Expenses | -2.92M | -6.10M | -5.41M | -1.55M | -4.95M | -5.56M | -1.17M | -3.11M | -1.54M | -4.39M | -260.00K | 18.00 | 1.43K | 22.00 | 339.00 |
Income Before Tax | -6.89M | -9.28M | -8.43M | -7.62M | -10.79M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | 592.00 | -32.41K |
Income Before Tax Ratio | -38.01% | -68.99% | -142.18% | -107.01% | -294.22% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | 0.59% | -85.27% |
Income Tax Expense | 187.85K | 204.92K | 1.89M | 907.60K | 4.04M | -1.01M | 1.37M | 6.29M | 1.75M | 1.00M | -260.00K | -11.81K | -110.00 | 1.32K | -89.00 |
Net Income | -7.08M | -9.48M | -10.31M | -8.53M | -14.83M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | -726.00 | -32.41K |
Net Income Ratio | -39.05% | -70.52% | -173.99% | -119.75% | -404.43% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | -0.72% | -85.27% |
EPS | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
EPS Diluted | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
Weighted Avg Shares Out | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
Weighted Avg Shares Out (Dil) | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
General Cannabis Corp Expands Convertible Financing Round and Adds Additional Capital Partner
General Cannabis Corp Strengthens Balance Sheet by Raising New Capital, Retiring Existing Debt and Extinguishing Put Obligation
General Cannabis Is A Strong Buy With Recent Acquisitions
With the Help of Tiffany Haddish, Josh Peck, and Natalie Mariduena, vitafusionTM Gummy Vitamins Announces Completion of Fruitful Milestone: Planting 200,000 Fruit Trees in Underserved Communities
Don’t Miss The Forest for The Trees with Alphabet Stock
Rising High: Ontario AG allows delivery, pick-up at cannabis stores KERN;CANN;ZYNE;TCNNF;TLRY;IGC;CRON;CGC;CTST;ACB;APHA;CVSI;OGI
Source: https://incomestatements.info
Category: Stock Reports